Form 4: Core Labs SVP Awarded Performance Shares

Core Laboratories Inc. SVP Gwendolyn Gresham received an award of 33,490 performance shares tied to ROIC and TSR metrics over a three-year period.

Summary

• Gwendolyn Gresham, Senior Vice President (SVP) of Core Laboratories Inc. /DE/ [CLB], was granted 33,490 performance shares.
• The award vests following a three-year performance period from January 1, 2026, to December 31, 2028.
• Vesting is contingent on Core Laboratories' Return on Invested Capital (ROIC) performance relative to its Bloomberg Peer Group (BPG).
• 50% of the award vests if the company is in the top 35th percentile of ROIC, 100% at the 55th percentile, and 175% at or above the 85th percentile.
• The number of vesting shares will be interpolated on a straight-line basis between these ROIC percentiles.
• Shares vesting above 100% of the award will be reduced by one-half if the absolute total shareholder return (TSR) for the performance period is negative.
• The award survives termination of employment due to death, disability, termination by the Company without cause, or retirement at 62 years of age or older.
• All shares, if vested, will be distributed on December 31, 2028.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies a strong alignment of executive incentives with long-term shareholder value creation through performance-based metrics. The structure encourages management to focus on capital efficiency and shareholder returns.

Positives

• The performance share award aligns the interests of a key executive (SVP Gwendolyn Gresham) directly with shareholder value creation through Return on Invested Capital (ROIC) and Total Shareholder Return (TSR) metrics.
• The inclusion of a negative Total Shareholder Return (TSR) clawback mechanism for shares vesting above 100% provides an additional safeguard, ensuring that outsized awards are not granted during periods of overall shareholder loss.

Negatives

• The potential for significant dilution exists if the company achieves high performance, leading to the vesting of up to 175% of the initial 33,490 performance shares.

Risks

• Failure to meet Return on Invested Capital (ROIC) targets among the Bloomberg Peer Group (BPG) could result in a reduced number of shares vesting, potentially as low as 50% or 0% of the target award.
• Negative absolute Total Shareholder Return (TSR) during the performance period could reduce the number of shares vesting above 100% of the award by one-half.

Future Outlook

The future outlook for this specific award is tied to Core Laboratories' financial performance, specifically its Return on Invested Capital (ROIC) relative to its peer group and its absolute Total Shareholder Return (TSR) over the three-year period ending December 31, 2028. The company aims to achieve ROIC performance at or above the 85th percentile of its Bloomberg Peer Group to maximize the vesting of these performance shares.

Industry Context

StockSavvy.ai notes that performance-based equity awards, particularly those tied to metrics like ROIC and TSR, are a common practice in the energy services and technology sector. This approach is designed to incentivize long-term value creation and align executive compensation with shareholder returns, reflecting a broader industry trend towards more rigorous performance-linked pay structures.

Comparison to Industry Standards

• Performance-based equity awards linked to ROIC and TSR are standard practice among publicly traded companies, including peers in the oilfield services sector such as Schlumberger, Halliburton, and Baker Hughes, which also utilize similar long-term incentive plans to align executive interests with company performance.
• The use of a peer group (Bloomberg Peer Group) for relative performance comparison is a common and robust method to ensure that executive compensation reflects performance against direct competitors, a practice seen across various industries to mitigate market-wide fluctuations.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased long-term value as executive compensation is directly tied to key performance indicators like ROIC and TSR, aligning management's focus with shareholder interests.
• Employees: The performance-based nature of the award for a senior executive may set a precedent or influence future compensation structures within the company, potentially impacting morale or expectations.

Next Steps

• The Compensation Committee will measure and determine the company's Return on Invested Capital (ROIC) and Total Shareholder Return (TSR) performance at the end of the performance period on December 31, 2028.
• The number of common shares vesting from the award will be determined and distributed on December 31, 2028, based on the measured performance.

Key Dates

Keywords

Core Laboratories, CLB, Performance Shares, Executive Compensation, SEC Form 4, Insider Transaction, Return on Invested Capital, Total Shareholder Return, Equity Award, Vesting